Two research studies were conducted in 2013 that both provided interesting new findings on the benefit of stereotactic radiosurgery (SRS) for brain tumor treatment.
Study 1 – Announced by the American Society of Radiation Oncology (ASTRO) in September 2013, the study found data indicating that adult cancer patients, under the age of 50 who had a limited number of brain metastases have improved overall survival rates after SRS treatment alone when not combined with whole brain radiation therapy (WBRT). Although the optimal treatment for brain metastases is currently unknown, the research may have determined if SRS has a therapeutic advantage over WBRT for patients with the disease. Click here to read more about this study.
Study 2 – Researchers from the University of North Carolina School of Medicine conducted a study on 52 patients with metastatic brain tumors and found that patient response to treatment with SRS within the first six-to-twelve weeks can indicate whether continuous monitoring after treatment is necessary. The study may have determined a reduced need for monitoring in patients who respond well to SRS. To read more about this study, click here.
This is not intended as medical advice to replace the expertise and judgment of your health care team. It is intended to help you and your family make informed decisions, together with your doctor.